Predictors of Critical Care Needs after IV Thrombolysis for Acute Ischemic Stroke
Intravenous (IV) tissue plasminogen activator (tPA) is the only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke. Post tPA patients are typically monitored in an intensive care unit (ICU) for at least 24 hours. However, rigorous evidence to support this practice is lac...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Béarla |
| Foilsithe / Cruthaithe: |
2014
|
| Rochtain ar líne: | https://doi.org/10.1371/journal.pone.0088652 https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0088652&type=printable |
| Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|